Why is CRSP stock down today?

CRISPR Therapeutics (CRSP) is actually up 2.37% today, not down. The strongest down-direction factors right now are: Spillover, Short interest, Quality, Sector momentum, News tone — the engine sees these but the market's pricing the opposite story today.

← CRSP FULL ANALYSIS

CRSP is up today, not down — what the down-side factors look like

CRISPR Therapeutics · Healthcare

Today\'s move

+2.37%$59.50

Note: CRSP is actually up today, not down. The factors that would explain a down move are below — they\'re present in the engine but the market\'s pricing the opposite story right now.

Strongest down-side factors right now

Each Framler factor is independently scored 0-100. Items below are the ones furthest from neutral (50) in the down direction. Engine verdict: bullish. Composite Framler score: 70/100. Regime: transition.

1Spillover15POOR

2Short interest20POOR

3Quality26WEAK

4Sector momentum28WEAK

5News tone39WEAK

Pattern firing

Earnings beat confirmed by price + options

See full CRSP multi-factor analysis →

About this breakdown

The "why" page is a snapshot of the Framler engine\'s 13-factor scoring for CRSP on today\'s pass. Direction-aligned factors are those whose individual score is at least 5 points away from neutral (50) in the requested direction. The engine refreshes daily at 06:00 UTC; this page revalidates every 10 minutes so the read tracks the fresh score.

CRSP forecast → · CRSP next earnings → · How the score is built →